Successful treatment of recalcitrant malar rash in a patient with cutaneous lupus erythematosus with efalizumab.
Hamprecht
A
A
Tüting
T
T
Bieber
T
T
Wenzel
J
J
D000287:Administration, Topical; D000328:Adult; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized; D002908:Chronic Disease; D003879:Dermatologic Agents / Q000008:administration & dosage*; D005076:Exanthema / Q000188:drug therapy*; D005148:Facial Dermatoses / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008178:Lupus Erythematosus, Cutaneous / Q000150:complications*; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D003879:Dermatologic Agents; C472181:efalizumab